TARS
Price:
$46.21
Market Cap:
$1.76B
Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as to treat meibomian gland disease. The company is also developing TP-04 for the treatment of rosacea; and TP-05 for Lyme prophylaxis and community malaria reduction. In addition, the company develops lotilaner to address diseases across therapeutic categories in human medicine, including eye care, dermatology, and other diseases. Tarsus Pharmaceutical...[Read more]
Industry
Biotechnology
IPO Date
2020-10-16
Stock Exchange
NASDAQ
Ticker
TARS
According to Tarsus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Tarsus Pharmaceuticals, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), TARS's Dividend Yield was at its highest in in the March 2018 quarter at 0%. The Dividend Yield was at its lowest in in the March 2018 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Tarsus Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
Year | Dividend Yield | Change |
---|---|---|
2023 | 0% | 0% |
2022 | 0% | 0% |
2021 | 0% | 0% |
2020 | 0% | 0% |
2019 | 0% | 0% |
The current Dividend Yield of Tarsus Pharmaceuticals, Inc. (TARS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Tarsus Pharmaceuticals, Inc.’s Dividend Yield is less than LianBio (3.01%), less than Aldeyra Therapeutics, Inc. (0%), less than Travere Therapeutics, Inc. (0%), less than Eton Pharmaceuticals, Inc. (0%), less than Connect Biopharma Holdings Limited (0%), less than Acumen Pharmaceuticals, Inc. (0%), less than Nuvation Bio Inc. (0%), less than Eledon Pharmaceuticals, Inc. (0%), less than Opthea Limited (0%), less than Centessa Pharmaceuticals plc (0%), less than Nuvalent, Inc. (0%), less than Genfit S.A. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than Ikena Oncology, Inc. (0%), less than Stoke Therapeutics, Inc. (0%), less than PepGen Inc. (0%), less than Tyra Biosciences, Inc. (0%), less than Entrada Therapeutics, Inc. (0%), less than Pharvaris N.V. (0%), less than Rallybio Corporation (0%),
Company | Dividend Yield | Market cap |
---|---|---|
3.01% | $34.47M | |
0% | $307.80M | |
0% | $1.41B | |
0% | $215.73M | |
0% | $66.30M | |
0% | $177.24M | |
0% | $764.36M | |
0% | $280.20M | |
0% | $628.43M | |
0% | $1.80B | |
0% | $6.25B | |
0% | $286.89M | |
0% | $542.54M | |
0% | $301.22M | |
0% | $98.77M | |
0% | $83.00M | |
0% | $689.69M | |
0% | $221.28M | |
0% | $865.93M | |
0% | $661.04M | |
0% | $1.29B | |
0% | $42.32M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tarsus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Tarsus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Tarsus Pharmaceuticals, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Tarsus Pharmaceuticals, Inc. (TARS)?
What is the highest Dividend Yield for Tarsus Pharmaceuticals, Inc. (TARS)?
What is the 3-year average Dividend Yield for Tarsus Pharmaceuticals, Inc. (TARS)?
What is the 5-year average Dividend Yield for Tarsus Pharmaceuticals, Inc. (TARS)?
How does the current Dividend Yield for Tarsus Pharmaceuticals, Inc. (TARS) compare to its historical average?